Matt Hewitt
Stock Analyst at Craig-Hallum
(0.54)
# 3,976
Out of 4,407 analysts
803
Total ratings
41.5%
Success rate
-1.8%
Average return
Main Sectors:
Stocks Rated by Matt Hewitt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Maintained: Buy | n/a | $37.83 | - | 48 | Jun 11, 2026 | |
| CYRX Cryoport | Maintained: Buy | n/a | $14.62 | - | 6 | Jun 11, 2026 | |
| MXCT MaxCyte | Maintained: Buy | n/a | $1.12 | - | 33 | Jun 11, 2026 | |
| SDGR Schrödinger | Maintained: Buy | n/a | $14.45 | - | 50 | Jun 11, 2026 | |
| BHST BioHarvest Sciences | Maintained: Buy | n/a | $3.20 | - | 18 | Jun 8, 2026 | |
| LGND Ligand Pharmaceuticals | Maintained: Buy | n/a | $255.54 | - | 67 | Jun 3, 2026 | |
| RGEN Repligen | Maintained: Buy | n/a | $130.59 | - | 56 | Jun 3, 2026 | |
| BLFS BioLife Solutions | Maintained: Buy | n/a | $26.10 | - | 33 | Jun 3, 2026 | |
| TKNO Alpha Teknova | Maintained: Buy | n/a | $4.20 | - | 20 | Jun 3, 2026 | |
| LFCR Lifecore Biomedical | Maintained: Buy | n/a | $5.65 | - | 37 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.00 | - | 2 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $17.98 | - | 6 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $9.14 | - | 20 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $5.20 | +53.85% | 15 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.682 | - | 10 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $4.69 | +27.93% | 55 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $2.40 | +275.00% | 49 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $4.98 | +0.40% | 31 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.27 | +208.37% | 27 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $26.13 | +53.08% | 30 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $16.32 | - | 51 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.47 | - | 1 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $110.65 | - | 1 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.0451 | - | 37 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $6.50 | +84.62% | 20 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.12 | - | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.73 | - | 12 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $18.55 | - | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $11.15 | n/a | 13 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $31.07 | n/a | 1 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $1.81 | n/a | 2 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.75 | n/a | 15 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $2.71 | n/a | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $13.32 | n/a | 1 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.34 | n/a | 22 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $17 | $12.10 | n/a | 2 | Oct 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $100 | $0.0002 | n/a | 1 | Jan 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $215 → $154 | $54.00 | n/a | 3 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $3.60 | n/a | 4 | Feb 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 | $78.20 | n/a | 1 | Nov 8, 2017 |
Omnicell
Jun 11, 2026
Maintained: Buy
Price Target: n/a
Current: $37.83
Upside: -
Cryoport
Jun 11, 2026
Maintained: Buy
Price Target: n/a
Current: $14.62
Upside: -
MaxCyte
Jun 11, 2026
Maintained: Buy
Price Target: n/a
Current: $1.12
Upside: -
Schrödinger
Jun 11, 2026
Maintained: Buy
Price Target: n/a
Current: $14.45
Upside: -
BioHarvest Sciences
Jun 8, 2026
Maintained: Buy
Price Target: n/a
Current: $3.20
Upside: -
Ligand Pharmaceuticals
Jun 3, 2026
Maintained: Buy
Price Target: n/a
Current: $255.54
Upside: -
Repligen
Jun 3, 2026
Maintained: Buy
Price Target: n/a
Current: $130.59
Upside: -
BioLife Solutions
Jun 3, 2026
Maintained: Buy
Price Target: n/a
Current: $26.10
Upside: -
Alpha Teknova
Jun 3, 2026
Maintained: Buy
Price Target: n/a
Current: $4.20
Upside: -
Lifecore Biomedical
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $5.65
Upside: -
Jun 2, 2026
Maintained: Hold
Price Target: n/a
Current: $4.00
Upside: -
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $17.98
Upside: -
May 19, 2026
Maintained: Buy
Price Target: n/a
Current: $9.14
Upside: -
May 12, 2026
Reiterated: Hold
Price Target: $8
Current: $5.20
Upside: +53.85%
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $0.682
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: $6
Current: $4.69
Upside: +27.93%
May 8, 2026
Reiterated: Buy
Price Target: $9
Current: $2.40
Upside: +275.00%
May 8, 2026
Reiterated: Buy
Price Target: $5
Current: $4.98
Upside: +0.40%
May 8, 2026
Reiterated: Buy
Price Target: $7
Current: $2.27
Upside: +208.37%
May 6, 2026
Reiterated: Buy
Price Target: $40
Current: $26.13
Upside: +53.08%
Apr 21, 2026
Maintained: Buy
Price Target: n/a
Current: $16.32
Upside: -
Mar 25, 2026
Maintained: Buy
Price Target: n/a
Current: $1.47
Upside: -
Feb 23, 2026
Maintained: Buy
Price Target: n/a
Current: $110.65
Upside: -
Feb 6, 2026
Maintained: Buy
Price Target: n/a
Current: $0.0451
Upside: -
Dec 16, 2025
Maintained: Buy
Price Target: $12
Current: $6.50
Upside: +84.62%
Dec 9, 2025
Maintained: Buy
Price Target: n/a
Current: $3.12
Upside: -
Oct 10, 2025
Maintained: Buy
Price Target: n/a
Current: $4.73
Upside: -
Jun 17, 2025
Rated: Hold
Price Target: n/a
Current: $18.55
Upside: -
Apr 25, 2025
Maintained: Buy
Price Target: n/a
Current: $11.15
Upside: n/a
Mar 18, 2025
Maintained: Buy
Price Target: n/a
Current: $31.07
Upside: n/a
Dec 18, 2024
Rated: Buy
Price Target: n/a
Current: $1.81
Upside: n/a
Aug 7, 2024
Maintained: Buy
Price Target: n/a
Current: $2.75
Upside: n/a
Feb 9, 2024
Rated: Buy
Price Target: $6
Current: $2.71
Upside: n/a
Sep 21, 2023
Maintained: Buy
Price Target: n/a
Current: $13.32
Upside: n/a
Feb 23, 2023
Rated: Hold
Price Target: n/a
Current: $7.34
Upside: n/a
Oct 4, 2019
Reiterated: Hold
Price Target: $16 → $17
Current: $12.10
Upside: n/a
Jan 18, 2019
Maintained: Hold
Price Target: $100
Current: $0.0002
Upside: n/a
Oct 31, 2018
Downgraded: Hold
Price Target: $215 → $154
Current: $54.00
Upside: n/a
Feb 27, 2018
Maintained: Buy
Price Target: $19
Current: $3.60
Upside: n/a
Nov 8, 2017
Reiterated: Hold
Price Target: $50
Current: $78.20
Upside: n/a